Cooper Companies | COO - Przychody Ze Sprzedaży





Obroty Zmiana Data
Abbott USD 12.59B 1.43B 2026-06
Align Technology USD 1.06B 20M 2026-06
AtriCure USD 153.6M 12.4M 2026-06
Bausch Health Companies USD 2.85B 350M 2026-06
Baxter International USD 2.96B 260M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Boston Scientific USD 5.44B 240M 2026-06
Cooper Companies USD 1.07B 15.3M 2026-06
Dentsply International USD 898M 18M 2026-06
Dexcom USD 1.31B 120M 2026-06
Edwards Lifesciences USD 1.74B 90M 2026-06
Globus Medical USD 789.61M 29.76M 2026-06
Haemonetics USD 339M 7M 2026-06
Inogen USD 74.93M 504K 2024-09
Insulet USD 801.7M 40M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
Intuitive Surgical USD 2.89B 120M 2026-06
J&J USD 25.31B 1.21B 2026-06
Medtronic USD 9.8B 0 2026-06
Merit Medical Systems USD 418.8M 36.9M 2026-06
Novartis USD 13.11B 750M 2026-03
ResMed USD 1.46B 60M 2026-06
STAAR Surgical USD 93.5M 0 2026-06
Steris USD 1.5B 90M 2026-06
Stryker USD 6.6B 600M 2026-06
Tandem Diabetes Care USD 254.6M 7.38M 2026-06
Teleflex USD 570.3M 22M 2026-06
Utah Medical Products USD 8.72M 323K 2026-03
Zimmer Biomet Holdings USD 2.18B 90M 2026-06